BridgeMD
New treatment option for Suicidal Ideation
Official title Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study
ClinicalTrials.gov ID: NCT07395752
What this study is testing
- What it's testing
- The goal of this clinical trial is to develop and evaluate youth-focused intervention programs for suicide and self-harm that are tailored to the psychological, developmental, and cultural characteristics of Korean adolescents and young adults. The study examines whether two structured, mindfulness-based intervention programs-one for middle and high school students and one for young adults-reduce suicidal ideation, self-harm behaviors, depressive symptoms, and emotion-regulation difficulties.
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 30
You may be able to join if
- General Criteria
- Aged between 15 and 30 years
- Obtained informed consent from a parent or legal guardian for participants under 19 years of age
- For the Self-Harm Group
- At least one incident of non-suicidal self-injury (NSSI) within the last 6 months
You likely can't join if
- Psychiatric and Developmental Conditions
- History of developmental disorders, including intellectual disability or autism spectrum disorder
- Diagnosis of schizophrenia or bipolar disorder
- Currently in an acute psychotic state
- Medical and Physical Conditions
- Presence of severe physical illness that interferes with daily life
See the full eligibility criteria
- General Criteria
- Aged between 15 and 30 years
- Obtained informed consent from a parent or legal guardian for participants under 19 years of age
- For the Self-Harm Group
- At least one incident of non-suicidal self-injury (NSSI) within the last 6 months
- Self-Harm Screening Inventory (SHSI) score of at least 1 (at least one "Yes" response)
- For the Suicide Attempt Group
- Suicide attempt within the last 6 months
- Depressive Symptom Inventory-Suicidality Subscale (DSI-SS) score of 3 or higher
- Psychiatric and Developmental Conditions
- History of developmental disorders, including intellectual disability or autism spectrum disorder
- Diagnosis of schizophrenia or bipolar disorder
- Currently in an acute psychotic state
- Medical and Physical Conditions
- Presence of severe physical illness that interferes with daily life
- Presence of metallic substances in the body (e.g., cardiac pacemakers, artificial heart valves) that are incompatible with fMRI
- Diagnosis of claustrophobia
- Current Treatment and Intervention
- Currently receiving regular and active cognitive behavioral therapy (CBT)
- Initiation of pharmacological treatment within the last 2 months
- Communication and Consent
- Inability to communicate fluently in Korean
- Failure to obtain informed consent from a parent or legal guardian for participants under 19 years of age
The study team makes the final eligibility decision.
Where it's taking place
- Suwon, Gyeonggi-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 30 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Suwon, Gyeonggi-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.